Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Replacement: Director/PDMR Shareholding

20 May 2016 14:33

RNS Number : 9068Y
Cello Group plc
20 May 2016
 

The following amendments have been made to the 'Director's Dealing' announcement released on 20 May 2016 at 1.30 pm under RNS No 9009Y.

 

The number of ordinary shares sold by Mark Bentley was 77,511, as opposed to 77,476 as previously announced. Accordingly, Mr Bentley's retained interest in ordinary shares is now 337,968, as opposed to 338,003 as previously announced.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

 

20 May 2016

Cello Group plc

("Cello" or the "Company")

 

Director's dealing

 

The Company has been notified that on 20 May 2016 the following directors of the Company exercised options under the PSP Option Scheme 2010 ("PSP") and the Approved Share Option Plan 2009 ("Approved") in order to increase their stakes in the Company.

Details of the exercise of options by the directors are set out below:

Director

Option Scheme

No of options held prior to exercise

No of options exercised

Exercise Price

No of options held post exercise

Mark Scott

PSP

1,550,000

770,000

10p

780,000

Mark Scott

Approved

72,000

72,000

31.5p

-

Mark Bentley

PSP

605,000

130,000

10p

475,000

Stephen Highley

PSP

420,000

50,000

10p

370,000

 

Following the exercise of these options the directors made the following sale of ordinary shares of 10 pence each in the Company ("Ordinary Shares"), these sales were made to cover exercise, tax and national insurance costs:

Director

No of ordinary shares prior to exercise and sale

No of ordinary shares sold

Sale Price

Retained interest in ordinary shares

% of issued share capital (as enlarged by the issue of options)

Mark Scott

964,379

486,204

97.2p

1,320,175

1.52%

Mark Bentley

285,479

77,511

97.2p

337,968

0.39%

Stephen Highley

2,046,889

22,285

97.2p

2,074,604

2.39%

 

 Contacts:

 

 Cello Group 020 7812 8460

 Mark Scott, Chief Executive

 Mark Bentley, Finance Director

 

 Cenkos Securities 0207 397 8900

 Bobbie Hilliam

 Harry Pardoe

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFFVEDIIFIR
Date   Source Headline
20th Jul 202012:21 pmRNSForm 8.3 - Cello Health Plc
17th Jul 20209:14 amRNSForm 8.3 - Cello Health PLC
16th Jul 20205:00 pmRNSForm 8.3 - Cello Health plc
16th Jul 20208:48 amRNSForm 8.3 - Cello Health PLC
16th Jul 20207:00 amRNSForm 8.3 - Cello Health Plc
15th Jul 20203:00 pmRNSUpdate re: antitrust clearances
15th Jul 20201:44 pmRNSForm 8.3 - Cello Health Plc
15th Jul 20201:21 pmRNSHolding(s) in Company
15th Jul 20208:55 amRNSForm 8.3 - Cello Health PLC
14th Jul 20201:33 pmRNSForm 8.3 - Cello Health plc
14th Jul 20208:51 amRNSForm 8.3 - Cello Health PLC
14th Jul 20208:04 amRNSHolding(s) in Company
14th Jul 20207:01 amRNSHolding(s) in Company
13th Jul 20203:15 pmBUSForm 8.3 - Cello Health plc
13th Jul 202010:51 amBUSForm 8.3 - CELLO HEALTH PLC
13th Jul 20208:18 amRNSForm 8.3 - Cello Health PLC
13th Jul 20207:00 amRNSHolding(s) in Company
13th Jul 20207:00 amRNSPublication of Scheme Document
10th Jul 20203:20 pmRNSForm 8.3 - Cello Health Plc
10th Jul 20203:17 pmRNSForm 8.3 - Cello Health PLC
10th Jul 20203:10 pmPRNForm 8.3 - Cello Health Plc
10th Jul 20201:34 pmBUSForm 8.3 - CELLO HEALTH PLC
10th Jul 202010:11 amRNSHolding(s) in Company
10th Jul 20209:41 amRNSForm 8.3 - Cello Health Plc
10th Jul 20208:51 amRNSForm 8.3 - Cello Health PLC
9th Jul 20206:20 pmRNSUpdate on letters of intent
9th Jul 20205:38 pmRNSHolding(s) in Company
9th Jul 20203:20 pmRNSForm 8.3 - Cello Health
9th Jul 20203:17 pmRNSForm 8.3 - CELLO HEALTH PLC
9th Jul 20203:08 pmRNSForm 8.3 - Cello Health PLC
9th Jul 20203:00 pmBUSForm 8.3 - Cello Health Plc
9th Jul 202012:33 pmRNSHolding(s) in Company
9th Jul 202011:31 amRNSForm 8.3 - Cello Health Plc
9th Jul 20209:20 amRNSForm 8.3 - Cello Health plc
9th Jul 20209:10 amRNSForm 8.3 - Cello Health PLC
9th Jul 20207:00 amRNSUpdate on irrevocable undertakings
8th Jul 20203:56 pmPRNForm 8.3 - Cello Health Plc
8th Jul 20203:00 pmBUSForm 8.3 - Cello Health Plc
8th Jul 20202:00 pmRNSForm 8.3 - Cello Health Plc
8th Jul 202012:45 pmRNSForm 8.3 - Cello Health plc
8th Jul 202010:35 amRNSForm 8.3 - Cello Health PLC
8th Jul 20209:55 amRNSForm 8.3 - Cello Health plc
8th Jul 20208:54 amPRNForm 8.3 - Cello Health plc
8th Jul 20207:00 amRNSUpdate on irrevocable undertakings
8th Jul 20207:00 amRNSForm 8.3 - Cello Health PLC
7th Jul 20203:20 pmRNSForm 8.3 - Cello Health
7th Jul 20203:19 pmRNSForm 8.3 - CELLO HEALTH PLC
7th Jul 20203:00 pmBUSForm 8.3 - Cello Health Plc
7th Jul 202010:08 amRNSCELLO HEALTH PLC
7th Jul 20209:16 amPRNForm 8.3 - Cello Health Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.